Connect with us

Health

May & Baker Signs Deal to Produce Sanofi Drugs

Published

on

May & Baker

By Modupe Gbadeyanka

May & Baker Plc has again cemented its position as one of the leading pharmaceutical manufacturing companies in Nigeria by signing an agreement with the local subsidiary of a notable French drugs company, Sanofi Nigeria Limited.

A statement from May & Baker, also locally known as M&B, explained that it would use its facility in Nigeria, which conform with the standard set by the World Health Organisation (WHO), to produce four brands of Sanofi drugs specifically tailored for the Nigerian and West African markets.

 “Under this agreement, May & Baker would use her World Health Organisation certified manufacturing facility to produce four product brands of Sanofi for sale in Nigeria and the West African market,” the firm stated in a notice to the Nigerian Stock Exchange (NSE) on Wednesday.

The products to be manufactured by May & Baker for Sanofi include Flagyl tablets and Suspension and Tarivid tablets, anti-infective medicines and Malareich tablets, an anti-malaria drug.

The company said it has capacity to produce six billion tablets and 37.5million 60ml liquid medicines annually.

“This agreement not only serves as a direct response to the call by the National Agency for Food and Drugs Administration and Control (NAFDAC) for pharmaceutical brand owners to localise their production using locally available capacity to produce quality products in Nigeria but also a step forward in Nigeria’s quest for medicine security and self-sufficiency,” the pharmaceutical company emphasised.

May & Baker has invested heavily in setting up internationally standard production facility and obtain WHO Good Manufacturing Practice (GMP) certification to enable her extend services to other products owners who might wish to heed the call to localise their medicine production in Nigeria.

May & Baker is the first pharmaceutical manufacturing company in Nigeria founded on September 4, 1944. The company went through different ownerships of foreign multinationals but became fully indigenous in 2002. It was listed on the local bourse in 1994 where it has won the coveted award of sectoral leadership of Healthcare sector six times.

In 2008, the company was awarded the International Organization for Standardization (ISO) Quality, Management Certificate, in recognition of the conformity of her management system to best international standards. This was further upgraded in 2017 to NIS ISO 9001:2015.

The company has won several other awards including the PMGMAN awards for the attainment of WHO GMP. In 2018, May & Baker also won the highly coveted National Productivity Order of Merit award.

Modupe Gbadeyanka is a fast-rising journalist with Business Post Nigeria. Her passion for journalism is amazing. She is willing to learn more with a view to becoming one of the best pen-pushers in Nigeria. Her role models are the duo of CNN's Richard Quest and Christiane Amanpour.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

NAFDAC Intensifies Efforts to Block Substandard Products from China, India

Published

on

Medication Drugs

By Adedapo Adesanya

The National Agency for Food and Drug Administration and Control (NAFDAC) is increasing efforts to block the entry of substandard and counterfeit products into Nigeria, particularly from China and India, the country’s two largest pharmaceutical trade partners.

This was revealed by Mrs Mojisola Adeyeye, the Director-General of the agency, emphasised that the Clean Report of Inspection and Analysis (CRIA) scheme has significantly strengthened regulatory control over imports from these nations.

The two nation’s account for 60 per cent of Nigeria’s pharmaceutical imports and yet, there is a lot of counterfeit and substandard medicines from these countries.

She said, “Because most of these drugs come from China and India, the CRIA scheme is operational in those two countries,” adding that, “It ensures that only safe and high-quality products are shipped while preventing the export of substandard and counterfeit products.”

She note that NAFDAC has appointed and accredited CRIA agents in China and India to conduct rigorous pre-shipment inspections to tackle the issue.

In addition to appointing CRIA agents in China and India, NAFDAC is collaborating with COTECNA, a global testing, inspection, and certification service provider, to enhance quality control measures.

Mrs Adeyeye urged stakeholders to engage with these CRIA agents before shipping any consignment to Nigeria, saying, “I strongly encourage you to engage with CRIA agents before shipping any consignment–that is, to our stakeholders– from China, India, or Nigeria. You have the flexibility to choose from any of the listed CRIA agents to ensure compliance and safeguard the quality of imported products.”

NAFDAC also introduced an electronic platform, the Port Inspection Data Capture and Risk Management System (PIDCARMS), to enhance document verification and streamline inspection processes.

Mrs Adeyeye noted that CRIA agents will ensure that rejected shipments carrying drugs will not find their way to the country.

She urged stakeholders to visit NAFDAC’s official website for guidelines on product registration, labelling, and shipment requirements to ensure compliance with regulatory standards in order to prevent such lapses and ensure only approved products enter Nigeria.

Continue Reading

Health

AXA’s Mind Health Report Highlights Importance of Workplace Wellness

Published

on

AXA's Mind Health Report Omowunmi Mabel Adewusi

Nigeria’s leading insurance company, AXA Mansard Insurance Plc, has announced the release of the AXA Mind Health Report 2025. This comprehensive study underscores the critical importance of mental health in the workplace and among young people.

According to Omowunmi Mabel Adewusi, General Counsel and Human Resource Director of AXA Mansard, the Mind Health Report is part of AXA’s ongoing commitment to promoting positive mental well-being and reducing stigma through holistic approaches.

She said, “The state of mind health in the world continues to give cause for concern, with a lot of people currently experiencing a mental health condition. This fifth edition of the report shows a worrying trend among our youth.

“We also observe an interesting trend in the workplace that reveals work impacts employees’ mental health either as a source of support or a source of issues.”

The AXA Mind Health Report 2025 reveals significant insights into the mental health landscape, highlighting the challenges that young adults and employees face.

According to the report, 44% of young adults (18-24) currently suffer from mental health conditions, with excessive use of social media and financial instability being major contributing factors.

Additionally, work-related stress, including excessive workload, tight deadlines, and a lack of work-life balance, remains a significant concern for employees.

Adewusi further emphasized the importance of prioritizing mental health in the workplace, explaining that mental health is a crucial aspect of overall well-being. Organizations must implement policies that support their employees.

“For us at AXA, this realization is at the heart of our We Care Programme, which affords our employees benefits such as flexible working hours, access to professional counselling services, monthly health workshops, a supportive work environment, menstrual, extended paternity, and caregiver leave benefits.

“The findings of the AXA Mind Health Report 2025 highlight the urgent need for proactive measures to address mental health issues in the workplace and among the youth. We are calling on business leaders, government agencies, and other stakeholders to foster a wellness culture that promotes positive mental health and supports individuals in reaching their full potential.”

The 2025 study, conducted in collaboration with IPSOS, aims to identify mental health and wellness issues in global society to build solutions to mitigate them. A total of 17,000 respondents from 16 countries participated in the survey.

Continue Reading

Health

Oyo Raises Entry Grade Level for University Graduate Nurses to 10

Published

on

graduate nurses ibadan

By Modupe Gbadeyanka

The entry grade level for nurses in the Oyo State civil service with university degree has been reviewed, the Provost of the Oyo State College of Nursing Sciences, Ibadan, Dr Gbonjubola Owolabi, has revealed.

The review was done by the state government through the Oyo State Civil Service Commission.

Recall that the National Council of Establishment (NCE) at its 43rd meeting in 2022 approved the placement of university graduate nurses on grade level 10.

At a meeting with 21 Nursing Tutors on Wednesday in Ibadan, Dr Owolabi said the state government has moved the category of nurses from grade 8, charging nursing tutors of the institution to be diligent in their duties and imbibe integrity and quality.

“The institution is out to train nursing and health practitioners and churn out quality manpower who can function effectively in community, primary, secondary, tertiary, and industrial health settings.

“I urge you to key into this vision, even as the present administration will not deprive you of your rights,” the provost stated.

Dr Owolabi, who said that the Oyo State government placed priority on integrity and quality, disclosed that “the institution has received necessary accreditations from the regulatory bodies for some courses.”

She lauded Governor Seyi Makinde for approving the promotion of the 21 tutors, saying such a gesture should be reciprocated with dedication to service.

In her vote of thanks, one of the lecturers, Mrs Abiola Elizabeth, lauded the management of the institution, saying the approval from the civil service had further accentuated the priority placed on the health sector by Oyo State government.

Continue Reading

Trending